Pisani P, Parkin DM, Bray F et al. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83: 18–29.
Roukos DH. Current status and future perspectives in gastric cancer management. Cancer Treat Rev 2000; 26: 243–55.
Boussioutas A, Li H, Liu J et al. Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer. Cancer Res 2003; 63: 2569–77.
Hippo Y, Taniguchi H, Tsutsumi S et al. Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res 2002; 62: 233–40.
Sakakura C, Hagiwara A, Nakanishi M et al. Differential gene expression profiles of gastric cancer cells established from primary tumour and malignant ascites. Br J Cancer 2002; 87: 1153–61.
Ji J, Chen X, Leung SY et al. Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines. Oncogene 2002; 21: 6549–56.
Liang G, Gonzales FA, Jones PA et al. Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2′-deoxycytidine. Cancer Res 2002; 62: 961–6.CrossRef
Hasegawa S, Furukawa Y, Li M et al. Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. Cancer Res 2002; 62: 7012–7.
Shaver W. Establishment of a new human gastric adenocarcinoma cell line. Gastroenterology 1988; 94: A422.
Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999; 21: 163–7.
Baylin SB, Herman JG, Graff JR et al. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998; 72: 141–96.CrossRef
Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000; 16: 168–74.
Esteller M, Herman JG. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol 2002; 196: 1–7.
Jones PA, Taylor SM. Cellular differentiation, cytidine analogs and DNA methylation. Cell 1980; 20: 85–93.
Bender CM, Pao MM, Jones PA. Inhibition of DNA methylation by 5-aza-2′-deoxycytidine suppresses the growth of human tumor cell lines. Cancer Res 1998; 58: 95–101.
Santi DV, Garrett CE, Barr PJ. On the mechanism of inhibition of DNA-cytosine methyltransferases by cytosine analogs. Cell 1983; 33: 9–10.
Michalowsky LA, Jones PA. Differential nuclear protein binding to 5-azacytosine-containing DNA as a potential mechanism for 5-aza-2′-deoxycytidine resistance. Mol Cell Biol 1987; 7: 3076–83.
Baugh LR, Hill AA, Brown El et al. Quantitative analysis of mRNA amplification by in vitro transcription. Nucleic Acids Res 2001; 29:E29.
Boon T, van der Bruggen P. Human tumor antigens recognized by T lymphocytes. J Exp Med 1996; 183: 725–9.
De Plaen E, Arden K, Traversari C et al. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 1994; 40: 360–9.
Tureci O, Chen YT, Sahin U et al. Expression of SSX genes in human tumors. Int J Cancer 1998; 77: 19–23.
Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol 1987; 196: 261–82.
Hippo Y, Yashiro M, Ishii M et al. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res 2001; 61: 889–95.
Wang J, Chen S. Screening and identification of gastric adenocarcinoma metastasis-related genes using cDNA microarray coupled to FDD-PCR. J Cancer Res Clin Oncol 2002; 128: 547–53.
Mori M, Mimori K, Yoshikawa Y et al. Analysis of the gene-expression profile regarding the progression of human gastric carcinoma. Surgery 2002; 131: S39–47.
Virtanen I, Korhonen M, Kariniemi AL et al. Integrins in human cells and tumors. Cell Differ Dev 1990; 32: 15–27.
Cross GS, Speer A, Rosenthal A et al. Deletions of fetal and adult muscle cDNA in Duchenne and Becker muscular dystrophy patients. EMBO J 1987; 6: 3277–83.
Henry MD, Cohen MB, Campbell KP. Reduced expression of dystroglycan in breast and prostate cancer. Hum Pathol 2001; 32: 791–5.
Sgambato A, Migaldi M, Montanari M et al. Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression. Am J Pathol 2003; 162: 849–60.
Shi Y, Ullrich SJ, Zhang J et al. A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity. J Biol Chem 2000; 275: 19167–76.
Tangye SG, Phillips JH, Lanier LL. The CD2-subset of the Ig super-family of cell surface molecules: receptor-ligand pairs expressed by NK cells and other immune cells. Semin Immunol 2000; 12: 149–57.
Guenzi E, Topolt K, Cornali E et al. The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. EMBO J 2001; 20: 5568–77.
Esteller M, Corn PG, Baylin SB et al. A gene hypermethylation profile of human cancer. Cancer Res 2001; 61: 3225–9.
Suzuki H, Gabrielson E, Chen W et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 2002; 31: 141–9.
Karpf AR, Peterson PW, Rawlins JT et al. Inhibition of DNA methyl-transferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells. Proc Natl Acad Sci USA 1999; 96: 14007–12.
Stark GR, Kerr IM, Williams BR et al. How cells respond to interferons. Annu Rev Biochem 1998; 67: 227–64.
Ozaki K, Nagata M, Suzuki M et al. Isolation and characterization of a novel human lung-specific gene homologous to lysosomal membrane glycoproteins 1 and 2: significantly increased expression in cancers of various tissues. Cancer Res 1998; 58: 3499–503.
Hannigan BM, Barnett YA, Armstrong DB et al. Thymidine kinases: the enzymes and their clinical usefulness. Cancer Biother 1993; 8: 189–97.
Peifer M, Polakis P. Wnt signaling in oncogenesis and embryogenesis-a look outside the nucleus. Science 2000; 287: 1606–9.
Koliopanos A, Kleeff J, Xiao Y et al. Increased arylhydrocarbon receptor expression offers a potential therapeutic target for pancreatic cancer. Oncogene 2002; 21: 6059–70.
Andersson P, McGuire J, Rubio C et al. A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors. Proc Natl Acad Sci USA 2002; 99: 9990–5.
Cameron EE, Bachman KE, Myohanen S et al. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 1999; 21: 103–7.